Neuropathic Pain in Patients With Degenerative Lumbar Stenosis
NCT ID: NCT06407167
Last Updated: 2025-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
120 participants
OBSERVATIONAL
2024-05-13
2026-05-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thus, it is necessary to clarify the role and the influence of the pain and its type on the perioperative period in patients with degenerative lumbar spinal stenosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Effectiveness and Prognostic Factors of Surgical and Non-surgical Management of Lumbar Spinal Stenosis
NCT03548441
Instability in the Lumbar Spine of Patients With Age Related Changes and Narrowing of the Spinal Canal (Spinal Stenosis)
NCT04406987
Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant
NCT01057641
Prevalence of Neuropathic Pain After Non-instrumented Lumbar Spinal Surgery
NCT06763224
Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion
NCT04469387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will be conducted at Priorov Central Institute for Trauma and Orthopedics, Moscow, Russia.
The study is expected to enroll at least 120 adult patients with degenerative lumbar stenosis. The neuropathy will be assessed preoperatively, and then the patient will undergo decompressive lumbar surgery without fusion.
The neuropathic pain will be evaluated according to DN4 preoperatively, each patient will be assigned to one of two groups depending on the total value of DN4 - with the presence of neuropathy (DN4\>= 4) and without neuropathy (DN4 \<4).
Postoperative evaluation will include 2 visits during one year to evaluate clinical and radiological outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neuropathic Pain
All patients will undergo lumbar decompression at stenosis levels (clinically and MRI confirmed) regardless of study group
DN4 (Douleur Neuropathique 4 Questions) questionnaire
DN4 includes a series of ten questions consisting of both sensory descriptors and signs related to bedside sensory examination
No Neuropathic Pain
All patients will undergo lumbar decompression at stenosis levels (clinically and MRI confirmed) regardless of study group
DN4 (Douleur Neuropathique 4 Questions) questionnaire
DN4 includes a series of ten questions consisting of both sensory descriptors and signs related to bedside sensory examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DN4 (Douleur Neuropathique 4 Questions) questionnaire
DN4 includes a series of ten questions consisting of both sensory descriptors and signs related to bedside sensory examination
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Radicular leg pain with or without neurogenic claudication with or without back pain;
3. Planned decompressive surgery for degenerative lumbar stenosis with or without degenerative spondylolisthesis;
4. Symptoms persisting for at least 3 months prior to surgery;
5. Given written Informed Consent;
6. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements
Exclusion Criteria
2. Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol;
3. Back or non-radicular pain of unknown etiology;
4. History or presence of any other major neurological disease or condition that may interfere with the study assessments (e.g. significant peripheral neuropathy, multiply sclerosis);
5. Any other condition or situation that the investigator believes may interfere with the safety of the subject or the intent and conduct of the study;
6. Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
N.N. Priorov National Medical Research Center of Traumatology and Orthopedics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aleksandr Krutko
Head of Neurosurgery Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Priorov National Medical Research Center of Traumatology and Orthopedics
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NS12-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.